Survivorship: Sexual Dysfunction (Male), Version 1.2013

Restricted access

Various anticancer treatments, especially those directed toward the pelvis, can damage blood vessels and reduce circulation of blood to the penis and/or damage the autonomic nervous system, resulting in higher rates of erectile dysfunction in survivors than in the general population. In addition, hormonal therapy can contribute to sexual problems, as can depression and anxiety, which are common in cancer survivors. This section of the NCCN Guidelines for Survivorship provides screening, evaluation, and treatment recommendations for male sexual problems, namely erectile dysfunction.

  • 1.

    Bober SL, Varela VS. Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol 2012;30:37123719.

  • 2.

    Donovan KA, Thompson LM, Hoffe SE. Sexual function in colorectal cancer survivors. Cancer Control 2010;17:4451.

  • 3.

    Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537544.

  • 4.

    Morreale MK. The impact of cancer on sexual function. Adv Psychosom Med 2011;31:7282.

  • 5.

    Vomvas D, Iconomou G, Soubasi E. Assessment of sexual function in patients with cancer undergoing radiotherapy—a single centre prospective study. Anticancer Res 2012;32:657664.

    • Search Google Scholar
    • Export Citation
  • 6.

    Forbat L, White I, Marshall-Lucette S, Kelly D. Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer. BJU Int 2012;109:98103.

    • Search Google Scholar
    • Export Citation
  • 7.

    White ID, Allan H, Faithfull S. Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy? Br J Cancer 2011;105:903910.

    • Search Google Scholar
    • Export Citation
  • 8.

    Fink HA, Mac Donald R, Rutks IR. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002;162:13491360.

    • Search Google Scholar
    • Export Citation
  • 9.

    Ganz PA, Greendale GA, Petersen L. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 2000;92:10541064.

    • Search Google Scholar
    • Export Citation
  • 10.

    Nehra A. Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions. Mayo Clin Proc 2009;84:139148.

    • Search Google Scholar
    • Export Citation
  • 11.

    Miles CL, Candy B, Jones L. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev 2007:CD005540.

  • 12.

    NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:8390.

  • 13.

    The Management of Erectile Dysfunction (2005). American Urological Association Web site. Available at: http://www.auanet.org/education/guidelines/erectile-dysfunction.cfm. Accessed February 9, 2014.

    • Search Google Scholar
    • Export Citation
  • 14.

    Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005;17:307319.

    • Search Google Scholar
    • Export Citation
  • 15.

    Monga M, Bettencourt R, Barrett-Connor E. Community-based study of erectile dysfunction and sildenafil use: the Rancho Bernardo study. Urology 2002;59:753757.

    • Search Google Scholar
    • Export Citation
  • 16.

    Ellis R, Smith A, Wilson S. The prevalence of erectile dysfunction in post-treatment colorectal cancer patients and their interests in seeking treatment: a cross-sectional survey in the west-midlands. J Sex Med 2010;7:14881496.

    • Search Google Scholar
    • Export Citation
  • 17.

    Hendren SK, O’Connor BI, Liu M. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 2005;242:212223.

    • Search Google Scholar
    • Export Citation
  • 18.

    Potosky AL, Davis WW, Hoffman RM. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004;96:13581367.

    • Search Google Scholar
    • Export Citation
  • 19.

    Resnick MJ, Koyama T, Fan KH. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 2013;368:436445.

  • 20.

    Schover LR, Fouladi RT, Warneke CL. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002;95:17731785.

  • 21.

    Siegel T, Moul JW, Spevak M. The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001;165:430435.

  • 22.

    Stanford JL, Feng Z, Hamilton AS. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000;283:354360.

    • Search Google Scholar
    • Export Citation
  • 23.

    Nehra A, Jackson G, Miner M. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2012;87:766778.

    • Search Google Scholar
    • Export Citation
  • 24.

    Hubanks JM, Umbreit EC, Karnes RJ, Myers RP. Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: a contemporary series. Eur Urol 2012;61:878884.

    • Search Google Scholar
    • Export Citation
  • 25.

    Yang L, Qian S, Liu L. Phosphodiesterase-5 inhibitors could be efficacious in the treatment of erectile dysfunction after radiotherapy for prostate cancer: a systematic review and meta-analysis. Urol Int 2012;90:339347.

    • Search Google Scholar
    • Export Citation
  • 26.

    Kloner RA, Hutter AM, Emmick JT. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol 2003;42:18551860.

  • 27.

    Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol 1999;83:21C28C.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 171 102 3
PDF Downloads 17 13 2
EPUB Downloads 0 0 0